Join to view full profile
1300 Crane StMenlo Park, CA 94025
Phone+1 650-498-6500
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Phillip Wong, MD is a board certified radiologist in Menlo Park, California. He is currently licensed to practice medicine in California, Hawaii, and New York.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Radiology-Diagnostic, 2001 - 2005
St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2000 - 2001
Stony Brook University Health Sciences Center School of MedicineClass of 2000
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Gastroenterology
Certifications & Licensure
CA State Medical License 2006 - 2028
HI State Medical License 2024 - 2028
NY State Medical License 2002 - 2009
American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 4 citationsSystemic Immunological Changes After Yttrium-90 Radioembolization: A Pilot Prospective Observational Study-Clinical Insights.Yuliya Kitsel, Elena N Petre, Phillip Wong, Vlasios Sotirchos, Efsevia Vakiani
Cardiovascular and Interventional Radiology. 2024-11-01 - 991 citationsGenetic basis for clinical response to CTLA-4 blockade in melanoma.Alexandra Snyder, Vladimir Makarov, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky
The New England Journal of Medicine. 2014-12-04 - 33 citationsStroke outcome in double-mutant antioxidant transgenic mice.Kenji Sampei, Allen S. Mandir, Yoshio Asano, Phillip C. Wong, Richard J. Traystman
Stroke. 2000-11-01
Grant Support
- TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and BiomarkerJOHNS HOPKINS UNIVERSITY2016–2028
- A diagnostic biomarker for amyotrophic lateral sclerosisJOHNS HOPKINS UNIVERSITY2023–2027
- Loss of TDP-43 disrupts the prefrontal neural activity and circuitry: relevance for TDP-43 linked ADRDUNIVERSITY OF WYOMING2022–2027
- TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and BiomarkerJOHNS HOPKINS UNIVERSITY2016–2026
- Loss of TDP-43 disrupts the prefrontal neural activity and circuitry: relevance for TDP-43 linked ADRDUNIVERSITY OF WYOMING2022–2025
